T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Richard P Junghans, PhD, MD Roger Williams Medical Center

First Page		Document Content
Date: 2014-01-13 09:36:10 Molecular biology Prostate cancer Retrovirus Prostate-specific membrane antigen Immunotherapy Cancer immunotherapy Neuroblastoma Lentivirus Medicine Oncology Immune system		T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Richard P Junghans, PhD, MD Roger Williams Medical Center Add to Reading List Source URL: osp.od.nih.gov Download Document from Source Website File Size: 683,28 KB Share Document on Facebook

	REPORTS Cite as: D. Niu et al., Sciencescience.aan4187Inactivation of porcine endogenous retrovirus in pigs using DocID: 1tMEN - View Document
	PERSPECTIVE PERSPECTIVE The discovery of HTLV-1, the first pathogenic human retrovirus DocID: 1tpgk - View Document
	MIT Committee on Assessment of Biohazards: Policy for Use of Lentiviral Vectors DocID: 1r6Cz - View Document
	MINA J. BISSELL, Ph.D. Distinguished Scientist, Division Biological Systems and Engineering Lawrence Berkeley National Laboratory One Cyclotron Road, MS 977–225A, Berkeley, CA 94720, USA Faculty: Graduate Groups in Com DocID: 1qUJL - View Document
	Reviews and Testimonials Koalas, along with their kin the kangaroos, are icons for the continent of Australia. These cuddly, teddy bear-like marsupials, while instantly recognizable, are little known outside of their nat DocID: 1qNBP - View Document